Valeant strikes price-cutting deal with Walgreens, hoping to polish its tarnished image

Carly Helfand

has been pummeled recently by drug pricing pushback, antitrust allegations and investigations into its business practices. But now, it has a new in hand that may bring it what it needs most: a credibility boost.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS